{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T05:07:45Z","timestamp":1793336865129,"version":"4.5.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,17]],"date-time":"2020-08-17T00:00:00Z","timestamp":1597622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,17]],"date-time":"2020-08-17T00:00:00Z","timestamp":1597622400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The use of trans-nasal pulmonary aerosol delivery via high-flow nasal cannula (HFNC) has expanded in recent years. However, various factors influencing aerosol delivery in this setting have not been precisely defined, and no consensus has emerged regarding the optimal techniques for aerosol delivery with HFNC. Based on a comprehensive literature search, we reviewed studies that assessed trans-nasal pulmonary aerosol delivery with HFNC by in vitro experiments, and in vivo, by radiolabeled, pharmacokinetic and pharmacodynamic studies. In these investigations, the type of nebulizer employed and its placement, carrier gas, the relationship between gas flow and patient\u2019s inspiratory flow, aerosol delivery strategies (intermittent unit dose vs continuous administration by infusion pump), and open vs closed mouth breathing influenced aerosol delivery. The objective of this review was to provide rational recommendations for optimizing aerosol delivery with HFNC in various clinical settings.<\/jats:p>","DOI":"10.1186\/s13054-020-03206-9","type":"journal-article","created":{"date-parts":[[2020,8,17]],"date-time":"2020-08-17T10:03:15Z","timestamp":1597658595000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["A narrative review on trans-nasal pulmonary aerosol delivery"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0121-1291","authenticated-orcid":false,"given":"Jie","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James B.","family":"Fink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronan","family":"MacLoughlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajiv","family":"Dhand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,17]]},"reference":[{"issue":"5","key":"3206_CR1","first-page":"563","volume":"45","author":"B Rochwerg","year":"2019","unstructured":"Rochwerg B, Granton D, Wang DX, Helviz Y, Einav S, Frat JP, et al. High flow nasal cannula compared with conventional oxygen therapy for acute hypoxemic respiratory failure: a systematic review and meta-analysis. Intensive Care Med. 2019;45(5):563\u201372.","journal-title":"Intensive Care Med"},{"issue":"4","key":"3206_CR2","doi-asserted-by":"crossref","first-page":"545","DOI":"10.4187\/respcare.07663","volume":"65","author":"J Li","year":"2020","unstructured":"Li J, Jing GQ, Scott JB. Year in review 2019: high-flow nasal cannula (HFNC) oxygen therapy for adult patients. Respir Care. 2020;65(4):545\u201357.","journal-title":"Respir Care"},{"key":"3206_CR3","doi-asserted-by":"crossref","unstructured":"Kang H, Zhao Z, Tong Z. Effect of high-flow nasal cannula oxygen therapy in immunocompromised subjects with acute respiratory failure. Respir Care. 2020;65(3):369\u201376.","DOI":"10.4187\/respcare.07205"},{"issue":"1","key":"3206_CR4","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/s13054-019-2465-y","volume":"23","author":"Y Zhu","year":"2019","unstructured":"Zhu Y, Yin H, Zhang R, Ye X, Wei J. High-flow nasal cannula oxygen therapy versus conventional oxygen therapy in patients after planned extubation: a systematic review and meta-analysis. Crit Care. 2019;23(1):180.","journal-title":"Crit Care"},{"issue":"1","key":"3206_CR5","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1186\/s13054-019-2596-1","volume":"23","author":"KM Fong","year":"2019","unstructured":"Fong KM, Au SY, Ng GWY. Preoxygenation before intubation in adult patients with acute hypoxemic respiratory failure: a network meta-analysis of randomized trials. Crit Care. 2019;23(1):319.","journal-title":"Crit Care"},{"issue":"6","key":"3206_CR6","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1089\/jamp.2019.1524","volume":"32","author":"J Dugernier","year":"2019","unstructured":"Dugernier J, Reychler G, Vecellio L, Ehrmann S. Nasal high-flow nebulization for lung drug delivery: theoretical, experimental, and clinical application. J Aerosol Med Pulm Drug Deliv. 2019;32(6):341\u201351.","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"issue":"11","key":"3206_CR7","doi-asserted-by":"crossref","first-page":"877","DOI":"10.2174\/1389201019666171219104217","volume":"18","author":"A Ari","year":"2017","unstructured":"Ari A. Aerosol drug delivery through high flow nasal cannula. Curr Pharm Biotechnol. 2017;18(11):877\u201382.","journal-title":"Curr Pharm Biotechnol"},{"issue":"7","key":"3206_CR8","doi-asserted-by":"crossref","first-page":"894","DOI":"10.4187\/respcare.05961","volume":"63","author":"AG Miller","year":"2018","unstructured":"Miller AG, Gentle MA, Tyler LM, Napolitano N. High-flow nasal cannula in pediatric patients: a survey of clinical practice. Respir Care. 2018;63(7):894\u20139.","journal-title":"Respir Care"},{"issue":"4","key":"3206_CR9","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1089\/jamp.2017.1432","volume":"31","author":"J Br\u00e4unlich","year":"2018","unstructured":"Br\u00e4unlich J, Wirtz H. Oral versus nasal high-flow bronchodilator inhalation in chronic obstructive pulmonary disease. J Aerosol Med Pulm Drug Deliv. 2018;31(4):248\u201354.","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"issue":"1","key":"3206_CR10","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s13613-018-0473-8","volume":"8","author":"F R\u00e9miniac","year":"2018","unstructured":"R\u00e9miniac F, Vecellio L, Bodet-Contentin L, Gissot V, Le Pennec D, Salmon Gandonniere C, et al. Nasal high-flow bronchodilator nebulization: a randomized cross-over study. Ann Intensive Care. 2018;8(1):128.","journal-title":"Ann Intensive Care"},{"issue":"4","key":"3206_CR11","doi-asserted-by":"crossref","first-page":"453","DOI":"10.4187\/respcare.06345","volume":"64","author":"YM Madney","year":"2019","unstructured":"Madney YM, Fathy M, Elberry AA, Rabea H, Abdelrahim ME. Aerosol delivery through an adult high-flow nasal cannula circuit using low-flow oxygen. Respir Care. 2019;64(4):453\u201361.","journal-title":"Respir Care"},{"issue":"5","key":"3206_CR12","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1159\/000501564","volume":"98","author":"J Li","year":"2019","unstructured":"Li J, Zhao M, Hadeer M, Luo J, Fink JB. Dose response to transnasal pulmonary administration of bronchodilator aerosols via nasal high-flow therapy in adults with stable chronic obstructive pulmonary disease and asthma. Respiration. 2019;98(5):401\u20139.","journal-title":"Respiration"},{"issue":"12","key":"3206_CR13","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1177\/1060028018782209","volume":"52","author":"MA Ammar","year":"2018","unstructured":"Ammar MA, Sasidhar M, Lam SW. Inhaled epoprostenol through noninvasive routes of ventilator support systems. Ann Pharmacother. 2018;52(12):1173\u201381.","journal-title":"Ann Pharmacother"},{"issue":"6","key":"3206_CR14","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3390\/pharmaceutics11060281","volume":"11","author":"J Li","year":"2019","unstructured":"Li J, Harnois LJ, Markos B, Roberts KM, Al Homoud S, Liu J, et al. Epoprostenol delivered via high flow nasal cannula for ICU subjects with severe hypoxemia comorbid with pulmonary hypertension or right heart dysfunction. Pharmaceutics. 2019;11(6):281.","journal-title":"Pharmaceutics"},{"issue":"2","key":"3206_CR15","doi-asserted-by":"crossref","first-page":"464","DOI":"10.3390\/jcm9020464","volume":"9","author":"J Li","year":"2020","unstructured":"Li J, Gurnani PK, Roberts KM, Fink JB, Vines D. The clinical impact of flow titration on epoprostenol delivery via high flow nasal cannula for icu patients with pulmonary hypertension or right ventricular dysfunction: a retrospective cohort comparison study. J Clin Med. 2020;9(2):464.","journal-title":"J Clin Med"},{"issue":"9","key":"3206_CR16","doi-asserted-by":"crossref","first-page":"e161","DOI":"10.4187\/respcare.03996","volume":"60","author":"SE Morgan","year":"2015","unstructured":"Morgan SE, Mosakowski S, Solano P, Hall JB, Tung A. High-flow nasal cannula and aerosolized beta agonists for rescue therapy in children with bronchiolitis: a case series. Respir Care. 2015;60(9):e161\u20135.","journal-title":"Respir Care"},{"issue":"7","key":"3206_CR17","doi-asserted-by":"crossref","first-page":"886","DOI":"10.4187\/respcare.05880","volume":"63","author":"J Valencia-Ramos","year":"2018","unstructured":"Valencia-Ramos J, Miras A, Cilla A, Ochoa C, Arnaez J. Incorporating a nebulizer system into high-flow nasal cannula improves comfort in infants with bronchiolitis. Respir Care. 2018;63(7):886\u201393.","journal-title":"Respir Care"},{"key":"3206_CR18","doi-asserted-by":"crossref","unstructured":"Al-Subu AM, Nguyen VT, AlAli Y, Yngsdal-Krenz RA, Lasarev MR, Eldridge MW, et al. Feasibility of aerosol bronchodilators delivery through high-flow nasal cannula in pediatric subjects with respiratory distress. Respir Care. 2020:[Epub ahead of print].","DOI":"10.4187\/respcare.07147"},{"issue":"1","key":"3206_CR19","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s13613-017-0278-1","volume":"7","author":"F Baudin","year":"2017","unstructured":"Baudin F, Buisson A, Vanel B, Massenavette B, Pouyau R, Javouhey E. Nasal high flow in management of children with status asthmaticus: a retrospective observational study. Ann Intensive Care. 2017;7(1):55.","journal-title":"Ann Intensive Care"},{"issue":"6","key":"3206_CR20","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1378\/chest.14-3161","volume":"147","author":"BM Fuller","year":"2015","unstructured":"Fuller BM, Mohr NM, Skrupky L, Fowler S, Kollef MH, Carpenter CR. The use of inhaled prostaglandins in patients with ards: a systematic review and meta-analysis. Chest. 2015;147(6):1510\u201322.","journal-title":"Chest"},{"issue":"6","key":"3206_CR21","doi-asserted-by":"crossref","first-page":"794","DOI":"10.4187\/respcare.03927","volume":"60","author":"NS Hill","year":"2015","unstructured":"Hill NS, Preston IR, Roberts KE. Inhaled therapies for pulmonary hypertension. Respir Care. 2015;60(6):794\u2013802.","journal-title":"Respir Care"},{"issue":"2","key":"3206_CR22","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1089\/jamp.2007.0662","volume":"21","author":"AR Bhashyam","year":"2008","unstructured":"Bhashyam AR, Wolf MT, Marcinkowski AL, Saville A, Thomas K, Carcillo JA, et al. Aerosol delivery through nasal cannulas: an in vitro study. J Aerosol Med Pulm Drug Deliv. 2008;21(2):181\u20138.","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"issue":"8","key":"3206_CR23","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1002\/ppul.21421","volume":"46","author":"A Ari","year":"2011","unstructured":"Ari A, Harwood R, Sheard M, Dailey P, Fink JB. In vitro comparison of heliox and oxygen in aerosol delivery using pediatric high flow nasal cannula. Pediatr Pulmonol. 2011;46(8):795\u2013801.","journal-title":"Pediatr Pulmonol"},{"issue":"5","key":"3206_CR24","doi-asserted-by":"crossref","first-page":"e250","DOI":"10.1097\/PCC.0b013e31828a7f79","volume":"14","author":"SA Perry","year":"2013","unstructured":"Perry SA, Kesser KC, Geller DE, Selhorst DM, Rendle JK, Hertzog JH. Influences of cannula size and flow rate on aerosol drug delivery through the vapotherm humidified high-flow nasal cannula system. Pediatr Crit Care Med. 2013;14(5):e250\u20136.","journal-title":"Pediatr Crit Care Med"},{"issue":"11","key":"3206_CR25","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1002\/ppul.23123","volume":"50","author":"FS Sunbul","year":"2015","unstructured":"Sunbul FS, Fink JB, Harwood R, Sheard MM, Zimmerman RD, Ari A. Comparison of hfnc, bubble cpap and sipap on aerosol delivery in neonates: an in-vitro study. Pediatr Pulmonol. 2015;50(11):1099\u2013106.","journal-title":"Pediatr Pulmonol"},{"issue":"2","key":"3206_CR26","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1089\/jamp.2015.1219","volume":"29","author":"F R\u00e9miniac","year":"2016","unstructured":"R\u00e9miniac F, Vecellio L, Heuze-Vourc'h N, Petitcollin A, Respaud R, Cabrera M, et al. Aerosol therapy in adults receiving high flow nasal cannula oxygen therapy. J Aerosol Med Pulm Drug Deliv. 2016;29(2):134\u201341.","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"issue":"9","key":"3206_CR27","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.4187\/respcare.05127","volume":"62","author":"PA Dailey","year":"2017","unstructured":"Dailey PA, Harwood R, Walsh K, Fink JB, Thayer T, Gagnon G, et al. Aerosol delivery through adult high flow nasal cannula with heliox and oxygen. Respir Care. 2017;62(9):1186\u201392.","journal-title":"Respir Care"},{"key":"3206_CR28","doi-asserted-by":"crossref","unstructured":"Madney YM, Fathy M, Elberry AA, Rabea H, Abdelrahim MEA. Abdelrahim M. Nebulizers and spacers for aerosol delivery through adult nasal cannula at low oxygen flow rate: An in-vitro study. J Drug Delivery Sci Technol 2017;39:260\u2013265..","DOI":"10.1016\/j.jddst.2017.04.014"},{"issue":"5","key":"3206_CR29","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3390\/pharmaceutics11050225","volume":"11","author":"J Li","year":"2019","unstructured":"Li J, Gong L, Fink JB. The ratio of nasal cannula gas flow to patient inspiratory flow on trans-nasal pulmonary aerosol delivery for adults: an in vitro study. Pharmaceutics. 2019;11(5):225.","journal-title":"Pharmaceutics"},{"issue":"6","key":"3206_CR30","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1002\/ppul.24274","volume":"54","author":"J Li","year":"2019","unstructured":"Li J, Gong L, Ari A, Fink JB. Decrease the flow setting to improve trans-nasal pulmonary aerosol delivery via \u201chigh-flow nasal cannula\u201d to infants and toddlers. Pediatr Pulmonol. 2019;54(6):914\u201321.","journal-title":"Pediatr Pulmonol"},{"issue":"1","key":"3206_CR31","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s41030-019-0086-x","volume":"5","author":"G Bennett","year":"2019","unstructured":"Bennett G, Joyce M, Sweeney L, MacLoughlin R. In vitro study of the effect of breathing pattern on aerosol delivery during high-flow nasal therapy. Pulmonary Therapy. 2019;5(1):43\u201354.","journal-title":"Pulmonary Therapy"},{"issue":"1","key":"3206_CR32","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s40635-019-0245-2","volume":"7","author":"G Bennett","year":"2019","unstructured":"Bennett G, Joyce M, Fernandez EF, MacLoughlin R. Comparison of aerosol delivery across combinations of drug delivery interfaces with and without concurrent high-flow nasal therapy. Intensive Care Med Exp. 2019;7(1):20.","journal-title":"Intensive Care Med Exp"},{"issue":"11","key":"3206_CR33","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1002\/ppul.24449","volume":"54","author":"A Ari","year":"2019","unstructured":"Ari A. Effect of nebulizer type, delivery interface, and flow rate on aerosol drug delivery to spontaneously breathing pediatric and infant lung models. Pediatr Pulmonol. 2019;54(11):1735\u201341.","journal-title":"Pediatr Pulmonol"},{"issue":"12","key":"3206_CR34","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1002\/ppul.24501","volume":"54","author":"MA Alalwan","year":"2019","unstructured":"Alalwan MA, Fink JB, Ari A. In vitro evaluation of aerosol drug delivery with and without high flow nasal cannula in children. Pediatr Pulmonol. 2019;54(12):1968\u201373.","journal-title":"Pediatr Pulmonol"},{"issue":"1\u20132","key":"3206_CR35","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1080\/01902148.2019.1599084","volume":"45","author":"J Valencia-Ramos","year":"2019","unstructured":"Valencia-Ramos J, Arnaez J, Benito JM, Miras A, Ochoa C, Beltran S. A comparative in vitro study of standard facemask jet nebulization and high-flow nebulization in bronchiolitis. Exp Lung Res. 2019;45(1\u20132):13\u201321.","journal-title":"Exp Lung Res"},{"issue":"1","key":"3206_CR36","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s12890-019-0807-9","volume":"19","author":"M Wallin","year":"2019","unstructured":"Wallin M, Tang P, Chang RYK, Yang M, Finlay WH, Chan HK. Aerosol drug delivery to the lungs during nasal high flow therapy: an in vitro study. BMC Pulm Med. 2019;19(1):42.","journal-title":"BMC Pulm Med"},{"issue":"2","key":"3206_CR37","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1002\/ppul.24589","volume":"55","author":"J Li","year":"2019","unstructured":"Li J, Wei W, Fink JB. In vitro comparison of unit dose vs infusion pump administration of albuterol via high-flow nasal cannula in toddlers. Pediatr Pulmonol. 2019;55(2):322\u20139.","journal-title":"Pediatr Pulmonol"},{"issue":"3","key":"3206_CR38","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/ppul.23509","volume":"52","author":"F R\u00e9miniac","year":"2017","unstructured":"R\u00e9miniac F, Vecellio L, Loughlin RM, Le Pennec D, Cabrera M, Vourc'h NH, et al. Nasal high flow nebulization in infants and toddlers: an in vitro and in vivo scintigraphic study. Pediatr Pulmonol. 2017;52(3):337\u201344.","journal-title":"Pediatr Pulmonol"},{"issue":"1","key":"3206_CR39","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s40635-020-0293-7","volume":"8","author":"J Li","year":"2020","unstructured":"Li J, Wu W, Fink JB. In vitro comparison between inspiration synchronized and continuous vibrating mesh nebulizer during trans-nasal aerosol delivery. Intensive Care Med Exp. 2020;8(1):6.","journal-title":"Intensive Care Med Exp"},{"issue":"8","key":"3206_CR40","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1002\/ppul.24326","volume":"54","author":"TE Corcoran","year":"2019","unstructured":"Corcoran TE, Saville A, Adams PS, Johnston DJ, Czachowski MR, Domnina YA, et al. Deposition studies of aerosol delivery by nasal cannula to infants. Pediatr Pulmonol. 2019;54(8):1319\u201325.","journal-title":"Pediatr Pulmonol"},{"issue":"5","key":"3206_CR41","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1089\/jamp.2017.1366","volume":"30","author":"J Dugernier","year":"2017","unstructured":"Dugernier J, Hesse M, Jumetz T, Bialais E, Roeseler J, Depoortere V, et al. Aerosol delivery with two nebulizers through high-flow nasal cannula: a randomized cross-over single-photon emission computed tomography-computed tomography study. J Aerosol Med Pulm Drug Deliv. 2017;30(5):349\u201358.","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"issue":"7","key":"3206_CR42","doi-asserted-by":"crossref","first-page":"320","DOI":"10.3390\/pharmaceutics11070320","volume":"11","author":"L Alcoforado","year":"2019","unstructured":"Alcoforado L, Ari A, Barcelar JM, Brandao SCS, Fink JB, de Andrade AD. Impact of gas flow and humidity on trans-nasal aerosol deposition via nasal cannula in adults: a randomized cross-over study. Pharmaceutics. 2019;11(7):320.","journal-title":"Pharmaceutics"},{"issue":"3","key":"3206_CR43","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0954-6111(95)90241-4","volume":"89","author":"AH Kendrick","year":"1995","unstructured":"Kendrick AH, Smith EC, Denyer J. Nebulizers--fill volume, residual volume and matching of nebulizer to compressor. Respir Med. 1995;89(3):157\u20139.","journal-title":"Respir Med"},{"issue":"6","key":"3206_CR44","doi-asserted-by":"crossref","first-page":"254","DOI":"10.3390\/pharmaceutics11060254","volume":"11","author":"JA McGrath","year":"2019","unstructured":"McGrath JA, O'Toole C, Bennett G, Joyce M, Byrne MA, MacLoughlin R. Investigation of fugitive aerosols released into the environment during high-flow therapy. Pharmaceutics. 2019;11(6):254.","journal-title":"Pharmaceutics"},{"key":"3206_CR45","unstructured":"Ministry of Health in New South Wales Australia. Humidified high flow nasal cannula oxygen guideline for metropolitan paediatric wards and eds: Http:\/\/www1.Health.Nsw.Gov.Au\/pds\/activepdsdocuments\/gl2016_004.Pdf. Accessed 7 Feb 2020."},{"issue":"6","key":"3206_CR46","volume":"9","author":"J Li","year":"2019","unstructured":"Li J, Luo J, Chen Y, Xie L, Fink JB. Effects of flow rate on transnasal pulmonary aerosol delivery of bronchodilators via high-flow nasal cannula for patients with copd and asthma: protocol for a randomised controlled trial. BMJ Open. 2019;9(6):e028584.","journal-title":"BMJ Open"},{"key":"3206_CR47","volume":"10","author":"I Moraa","year":"2018","unstructured":"Moraa I, Sturman N, McGuire TM, van Driel ML. Heliox for croup in children. Cochrane Database Syst Rev. 2018;10:CD006822.","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"3206_CR48","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1164\/ajrccm.163.1.2003025","volume":"163","author":"ML Goode","year":"2001","unstructured":"Goode ML, Fink JB, Dhand R, Tobin MJ. Improvement in aerosol delivery with helium-oxygen mixtures during mechanical ventilation. Am J Respir Crit Care Med. 2001;163(1):109\u201314.","journal-title":"Am J Respir Crit Care Med"},{"issue":"2 Pt 1","key":"3206_CR49","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1164\/ajrccm.154.2.8756810","volume":"154","author":"JB Fink","year":"1996","unstructured":"Fink JB, Dhand R, Duarte AG, Jenne JW, Tobin MJ. Aerosol delivery from a metered-dose inhaler during mechanical ventilation. An in vitro model. Am J Respir Crit Care Med. 1996;154(2 Pt 1):382\u20137.","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"3206_CR50","first-page":"837","volume":"55","author":"A Ari","year":"2010","unstructured":"Ari A, Areabi H, Fink JB. Evaluation of aerosol generator devices at 3 locations in humidified and non-humidified circuits during adult mechanical ventilation. Respir Care. 2010;55(7):837\u201344.","journal-title":"Respir Care"},{"issue":"10","key":"3206_CR51","first-page":"1336","volume":"54","author":"HL Lin","year":"2009","unstructured":"Lin HL, Fink JB, Zhou Y, Cheng YS. Influence of moisture accumulation in inline spacer on delivery of aerosol using metered-dose inhaler during mechanical ventilation. Respir Care. 2009;54(10):1336\u201341.","journal-title":"Respir Care"},{"issue":"6","key":"3206_CR52","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/j.jaci.2010.01.034","volume":"125","author":"I Amirav","year":"2010","unstructured":"Amirav I, Newhouse MT, Minocchieri S, Castro-Rodriguez JA, Schuepp KG. Factors that affect the efficacy of inhaled corticosteroids for infants and young children. J Allergy Clin Immunol. 2010;125(6):1206\u201311.","journal-title":"J Allergy Clin Immunol"},{"issue":"10","key":"3206_CR53","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1164\/rccm.200210-1167OC","volume":"168","author":"DD Miller","year":"2003","unstructured":"Miller DD, Amin MM, Palmer LB, Shah AR, Smaldone GC. Aerosol delivery and modern mechanical ventilation: in vitro\/in vivo evaluation. Am J Respir Crit Care Med. 2003;168(10):1205\u20139.","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"3206_CR54","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1089\/jamp.2015.1243","volume":"29","author":"JB Michotte","year":"2016","unstructured":"Michotte JB, Staderini E, Le Pennec D, Dugernier J, Rusu R, Roeseler J, et al. In vitro comparison of a vibrating mesh nebulizer operating in inspiratory synchronized and continuous nebulization modes during noninvasive ventilation. J Aerosol Med Pulm Drug Deliv. 2016;29(4):328\u201336.","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"issue":"1","key":"3206_CR55","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1089\/jamp.2016.1339","volume":"31","author":"JB Michotte","year":"2018","unstructured":"Michotte JB, Staderini E, Aubriot AS, Jossen E, Dugernier J, Liistro G, et al. Pulmonary drug delivery following continuous vibrating mesh nebulization and inspiratory synchronized vibrating mesh nebulization during noninvasive ventilation in healthy volunteers. J Aerosol Med Pulm Drug Deliv. 2018;31(1):33\u201341.","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"issue":"1","key":"3206_CR56","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13613-019-0560-5","volume":"9","author":"T Mauri","year":"2019","unstructured":"Mauri T, Spinelli E, Dalla Corte F, Scotti E, Turrini C, Lazzeri M, et al. Noninvasive assessment of airflows by electrical impedance tomography in intubated hypoxemic patients: an exploratory study. Ann Intensive Care. 2019;9(1):83.","journal-title":"Ann Intensive Care"},{"issue":"4","key":"3206_CR57","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1089\/jamp.2015.1229","volume":"29","author":"M Boon","year":"2016","unstructured":"Boon M, Jorissen M, Jaspers M, Augustijns P, Vermeulen FL, Proesmans M, et al. The influence of nebulized drugs on nasal ciliary activity. J Aerosol Med Pulm Drug Deliv. 2016;29(4):378\u201385.","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"issue":"9","key":"3206_CR58","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1164\/rccm.201605-0916OC","volume":"195","author":"T Mauri","year":"2017","unstructured":"Mauri T, Turrini C, Eronia N, Grasselli G, Volta CA, Bellani G, et al. Physiologic effects of high-flow nasal cannula in acute hypoxemic respiratory failure. Am J Respir Crit Care Med. 2017;195(9):1207\u201315.","journal-title":"Am J Respir Crit Care Med"},{"key":"3206_CR59","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.2147\/COPD.S104616","volume":"11","author":"J Br\u00e4unlich","year":"2016","unstructured":"Br\u00e4unlich J, K\u00f6hler M, Wirtz H. Nasal highflow improves ventilation in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2016;11:1077\u201385.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"3206_CR60","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jpeds.2017.06.006","volume":"189","author":"T Weiler","year":"2017","unstructured":"Weiler T, Kamerkar A, Hotz J, Ross PA, Newth CJL, Khemani RG. The relationship between high flow nasal cannula flow rate and effort of breathing in children. J Pediatr. 2017;189:66\u201371 e63.","journal-title":"J Pediatr"},{"issue":"5","key":"3206_CR61","doi-asserted-by":"crossref","first-page":"532","DOI":"10.4187\/respcare.05319","volume":"62","author":"Y Chikata","year":"2017","unstructured":"Chikata Y, Ohnishi S, Nishimura M. Humidity and inspired oxygen concentration during high-flow nasal cannula therapy in neonatal and infant lung models. Respir Care. 2017;62(5):532\u20137.","journal-title":"Respir Care"},{"issue":"6","key":"3206_CR62","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.pulmoe.2019.08.001","volume":"25","author":"L Pisani","year":"2019","unstructured":"Pisani L, Astuto M, Prediletto I, Longhini F. High flow through nasal cannula in exacerbated copd patients: a systematic review. Pulmonology. 2019;25(6):348\u201354.","journal-title":"Pulmonology"},{"issue":"4","key":"3206_CR63","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.rmed.2009.12.016","volume":"104","author":"H Rea","year":"2010","unstructured":"Rea H, McAuley S, Jayaram L, Garrett J, Hockey H, Storey L, et al. The clinical utility of long-term humidification therapy in chronic airway disease. Respir Med. 2010;104(4):525\u201333.","journal-title":"Respir Med"},{"key":"3206_CR64","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.2147\/COPD.S206111","volume":"14","author":"J Braunlich","year":"2019","unstructured":"Braunlich J, Dellweg D, Bastian A, Budweiser S, Randerath W, Triche D, et al. Nasal high-flow versus noninvasive ventilation in patients with chronic hypercapnic copd. Int J Chron Obstruct Pulmon Dis. 2019;14:1411\u201321.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"1","key":"3206_CR65","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13613-019-0597-5","volume":"9","author":"N Rittayamai","year":"2019","unstructured":"Rittayamai N, Phuangchoei P, Tscheikuna J, Praphruetkit N, Brochard L. Effects of high-flow nasal cannula and non-invasive ventilation on inspiratory effort in hypercapnic patients with chronic obstructive pulmonary disease: a preliminary study. Ann Intensive Care. 2019;9(1):122.","journal-title":"Ann Intensive Care"},{"issue":"12","key":"3206_CR66","first-page":"1344","volume":"79","author":"G Chanques","year":"2013","unstructured":"Chanques G, Riboulet F, Molinari N, Carr J, Jung B, Prades A, et al. Comparison of three high flow oxygen therapy delivery devices: a clinical physiological cross-over study. Minerva Anestesiol. 2013;79(12):1344\u201355.","journal-title":"Minerva Anestesiol"},{"issue":"10","key":"3206_CR67","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.4187\/respcare.02903","volume":"59","author":"L Golshahi","year":"2014","unstructured":"Golshahi L, Longest PW, Azimi M, Syed A, Hindle M. Intermittent aerosol delivery to the lungs during high-flow nasal cannula therapy. Respir Care. 2014;59(10):1476\u201386.","journal-title":"Respir Care"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-020-03206-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13054-020-03206-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-020-03206-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,16]],"date-time":"2021-08-16T23:16:36Z","timestamp":1629155796000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/s13054-020-03206-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,17]]},"references-count":67,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["3206"],"URL":"https:\/\/doi.org\/10.1186\/s13054-020-03206-9","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,17]]},"assertion":[{"value":"1 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Dr. Dhand reports remuneration from GSK Pharmaceuticals, Boehringer-Ingelheim, Bayer, Mylan, Teva, and Astra-Zeneca Pharmaceuticals outside the submitted work. Dr. Fink is Chief Science Officer for Aerogen Pharma Corp, San Mateo, CA, USA. Dr. MacLoughlin is the Senior Manager Science for Aerogen Ltd., Galway, Ireland. Dr. Li declares to receive research funding from Fisher & Paykel Healthcare, The Daniel and Ada Rice Foundation. None of the companies had a role in the conception of this review, in the literature search or interpretation, in the writing of the manuscript, or in the decision to publish the results.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"506"}}